Delays in access to new cancer medicines and unjustifiable price rises for old ones disadvantage patients unnecessarily
Amsterdam, The Netherlands. Cancer patients are living longer and in many cases the disease is becoming chronic rather than acute. Access to drugs that help extend life and improve quality of life, and fair prices…